Searched for
DUSA PHARMACEUTICALS
Sun Pharma gains 2% on winning patent infringement caseThe pharma giant made the announcement post markets hours of Wednesday.27 Dec, 2018, 10.11 AM IST- Sensex jumps over 300 points, Nifty reclaims 10,800; Sun Pharma up 2%Among Sensex stocks, 28 gained while only two declined.27 Dec, 2018, 09.45 AM IST
- Sun Pharma arm gets relief from US court in patent infringement caseThe lawsuit alleged trade secret misappropriation and patent infringement of DUSA's photodynamic therapy patents covering its product.26 Dec, 2018, 05.44 PM IST
- Sun Pharma's subsidiary files patent infringement suit against German drug maker BiofronteraDUSA has alleged that Biofrontera defendants misappropriated confidential and trade secret information from DUSA and improperly obtained co...11 Jul, 2018, 07.29 PM IST
- Credit Suisse upgrades Sun Pharma to 'outperform' from 'neutral'Credit Suisse has upgraded shares of Sun Pharmaceutical Industries to 'outperform' from 'neutral' and raised target price to Rs 925 from Rs...05 May, 2016, 01.57 PM IST
- Sun Pharma in talks to buy Sweden's Meda AB for up to $5 billion: ReportsSun Pharmaceutical Industries is said to be in talks to buy Sweden's pharma firm Meda AB in a deal worth up to $5 billion, according to med...03 Jun, 2013, 08.06 AM IST
- Sun Pharma is doing great but US Arm Taro may be peakingTaro's Q4 revenue fell sequentially, while local business continued to outperform industry.29 May, 2013, 08.53 AM IST
- Sun Pharma Q4 PAT seen 12% up at Rs 922 croreIt is likely to report a net profit of Rs 922 crore for quarter ended March 2013, up 12 per cent, as compared to a net profit of Rs 820 cro...27 May, 2013, 05.06 PM IST
- Brokers' call: Sun Pharma remains a buyMorgan Stanley has maintained a ‘Buy’ rating on Sun Pharmaceuticals with an ‘Overweight’ rating with a target price of Rs 1,159.14 May, 2013, 05.00 AM IST
- Hot stock: Morgan Stanley sees more upside in Sun PharmaMS has maintained 'Overweight' rating on Sun Pharma and added the stock to “Asia Best Idea”.13 May, 2013, 03.50 PM IST
- Sun Pharma Q3 net profit at Rs 881.30 croreSun Pharma today reported a consolidated net profit of Rs 881.30 crore for the third quarter ended December 31, 2012.08 Feb, 2013, 12.55 PM IST
- Sun Pharma's US-based subsidiary Caraco completes tender offer to acquire Dusa PharmaDrug firm Sun Pharmaceutical Industries today said its US-based subsidiary Caraco has successfully completed the tender offer to acquire Du...20 Dec, 2012, 09.39 PM IST
- Looking for larger acquisitions in key markets: Sun PharmaSun Pharmaceutical Industries today said it is looking forward to larger acquisitions as a part of its expansion plans.09 Nov, 2012, 02.52 PM IST
- Sun Pharmaceuticals to buy US-based DUSA for $230 million; stock gainsShares of Sun Pharma moved higher in trade of Friday as sentiment turned bullish after it signed a pact to buy US-based DUSA Pharmaceutical...09 Nov, 2012, 12.41 PM IST
- Sun Pharma to buy US-based DUSA Pharmaceuticals for $230 millionUnder the terms of agreement, a 100% subsidiary of Sun Pharma will commence a tender offer for all outstanding common stock of DUSA at a pr...09 Nov, 2012, 11.07 AM IST
- Sun Pharma to acquire US dermatology company DUSA PharmaSun Pharma is to acquire US-based DUSA Pharmaceuticals, Inc, a dermatology company focused on developing and marketing its Levulan (aminole...08 Nov, 2012, 08.59 PM IST
- India Inc on shopping spree, announces deals worth Rs 2,850 croreIn major deals worth Rs 2,850 crore, homegrown companies today announced acquisitions of assets from global firms with Sun Pharma buying DU...08 Nov, 2012, 08.26 PM IST
Load More
